Wird geladen...
Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution
Glaucoma is a leading cause of irreversible blindness worldwide. The reduction of intraocular pressure has been well established as an effective treatment to prevent both the development and the progression of all forms of glaucoma. Bimatoprost 0.03% ophthalmic solution, introduced in 2001, is a syn...
Gespeichert in:
| Veröffentlicht in: | Clin Ophthalmol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5513827/ https://ncbi.nlm.nih.gov/pubmed/28744094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S118689 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|